DUBLIN--(BUSINESS WIRE)--"A Practical Overview of Pre-Filled Syringes Training Course (Nov 5th - Nov 6th, 2025)" training has been added to ResearchAndMarkets.com's offering. This course offers a ...

7 October 2013 - Newcastle: Aesica, the global contract development and manufacturing organisation (CDMO), has extended its aseptic capabilities at its Nottingham site with the acquisition of new ...

CAMBRIDGE, Mass.--(BUSINESS WIRE)--Ipsen Biopharmaceuticals, an affiliate of Ipsen (Euronext: IPN; ADR: IPSEY), announced today that the United States Food and Drug Administration (FDA) has approved a ...

Amsino International, Inc. is a global medical device manufacturer and supplier focused on delivering high-quality, reliable products to healthcare providers. With a strong emphasis on innovation, ...

WUXI, China, June 5, 2022 /PRNewswire/ -- WuXi Biologics ("WuXi Bio") (2269.HK), a global CRDMO service company, announced it has successfully launched the GMP operation of its new drug product ...

WuXi Biologics, a CDMO, launched the GMP operation of its new drug product facility DP5 located in Wuxi, China. The DP5 is the ninth operational drug product facility in the global network of WuXi ...

MedPro Safety Products has introduced a pre-filled safety syringe. The device contains a precise dose of pharmaceutical stored within a syringe system. The product also is equipped with a passive ...

Novartis announces the launch in Europe of the Lucentis pre-filled syringe (PFS), which is specifically designed for intraocular injection The Lucentis PFS can lead to improved patient treatment via a ...

NEWARK, Del.--(BUSINESS WIRE)--W. L. Gore & Associates, Inc. (“Gore”), a global materials science company, recently announced the commercial launch of the 0.5 mL silicone-free* GORE® IMPROJECT® ...

Please provide your email address to receive an email when new articles are posted on . The prefilled syringe is indicated for wet age-related macular degeneration, diabetic macular edema and retinal ...

Investing.com -- Formycon has launched FYB201/Ranivisio as the first ranibizumab biosimilar available in a pre-filled syringe format in Europe, starting in France in October 2025. The company plans to ...